Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation

Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis

(2010) Rolando Pérez-Lorenzo et al.   CARCINOGENESIS

Cellular and Pharmacological Selectivity of the Peroxisome Proliferator-Activated Receptor- /  Antagonist GSK3787

(2010) P. S. Palkar et al.   MOLECULAR PHARMACOLOGY

A selective cyclooxygenase-2 inhibitor prevents inflammation-related squamous cell carcinogenesis of the forestomach via duodenogastric reflux in rats

(2009) Masaru Oba et al.   CANCER

Inhibition of Peroxisome Proliferator-Activated Receptor   Increases Estrogen Receptor-Dependent Tumor Specification

(2009) Y. Yin et al.   CANCER RESEARCH

PPARδ and PGC1α act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress

(2009) Faisal Ali et al.   CARDIOVASCULAR RESEARCH

TGF-β-induced epithelial to mesenchymal transition

(2009) Jian Xu et al.   CELL RESEARCH

S100A8/A9: A Janus-faced molecule in cancer therapy and tumorgenesis

(2009) Saeid Ghavami et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Targeted Genetic Disruption of Peroxisome Proliferator–Activated Receptor-δ and Colonic Tumorigenesis

(2009) Xiangsheng Zuo et al.   JNCI-Journal of the National Cancer Institute

Modulation of transcription by the peroxisome proliferator-activated receptor  -binding RNA aptamer in colon cancer cells

(2009) H. Kwak et al.   MOLECULAR CANCER THERAPEUTICS

15-Hydroxyeicosatetraenoic Acid Is a Preferential Peroxisome Proliferator-Activated Receptor  /  Agonist

(2009) S. Naruhn et al.   MOLECULAR PHARMACOLOGY

Peroxisome proliferator-activated receptor δ and gastric cancer (Review)

(2009) Sung   ONCOLOGY REPORTS

Chemical Carcinogenesis of the Gastrointestinal Tract in Rodents: An Overview with Emphasis on NTP Carcinogenesis Bioassays

(2009) Sundeep A. Chandra et al.   TOXICOLOGIC PATHOLOGY

Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells

(2009) Chan Woo Cheon et al.   WORLD JOURNAL OF GASTROENTEROLOGY

PPARβ/δ agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-κB signals

(2008) ShouWei Han et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Peroxisome Proliferator–Activated Receptor β/δ Expression and Activation in Lung Cancer

(2008) Tetyana V. Pedchenko et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Gastric cancer

(2008) P. Lochhead et al.   BRITISH MEDICAL BULLETIN

Role of peroxisome-proliferator-activated receptor β/δ (PPARβ/δ) in gastrointestinal tract function and disease

(2008) Jeffrey M. Peters et al.   CLINICAL SCIENCE

The Simultaneous Expression of Peroxisome Proliferator-Activated Receptor Delta and Cyclooxygenase-2 May Enhance Angiogenesis and Tumor Venous Invasion in Tissues of Colorectal Cancers

(2008) Masahiro Yoshinaga et al.   DIGESTIVE DISEASES AND SCIENCES

PPARδ is pro-tumorigenic in a mouse model of COX-2-induced mammary cancer

(2008) Mallika Ghosh et al.   PROSTAGLANDINS & OTHER LIPID MEDIATORS

PPARγand PPARδas Modulators of Neoplasia and Cell Fate

(2008) Robert I. Glazer et al.   PPAR Research

Rosiglitazone Suppresses the Growth and Invasiveness of SGC-7901 Gastric Cancer Cells and Angiogenesis In Vitro via PPARγDependent and Independent Mechanisms

(2008) Qing He et al.   PPAR Research